239 related articles for article (PubMed ID: 11320386)
1. DNA content as a prognostic marker in patients with oral leukoplakia.
Sudbø J; Kildal W; Risberg B; Koppang HS; Danielsen HE; Reith A
N Engl J Med; 2001 Apr; 344(17):1270-8. PubMed ID: 11320386
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of oral precancerous lesions].
Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
[TBL] [Abstract][Full Text] [Related]
3. The influence of resection and aneuploidy on mortality in oral leukoplakia.
Sudbø J; Lippman SM; Lee JJ; Mao L; Kildal W; Sudbø A; Sagen S; Bryne M; El-Naggar A; Risberg B; Evensen JF; Reith A
N Engl J Med; 2004 Apr; 350(14):1405-13. PubMed ID: 15070790
[TBL] [Abstract][Full Text] [Related]
4. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia.
Sudbø J; Bryne M; Johannessen AC; Kildal W; Danielsen HE; Reith A
J Pathol; 2001 Jul; 194(3):303-10. PubMed ID: 11439362
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
[TBL] [Abstract][Full Text] [Related]
6. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers of the risk of oral cancer.
Lippman SM; Hong WK
N Engl J Med; 2001 Apr; 344(17):1323-6. PubMed ID: 11320393
[No Abstract] [Full Text] [Related]
8. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of DNA ploidy status in patients with oral leukoplakia.
Bremmer JF; Brakenhoff RH; Broeckaert MA; Beliën JA; Leemans CR; Bloemena E; van der Waal I; Braakhuis BJ
Oral Oncol; 2011 Oct; 47(10):956-60. PubMed ID: 21880540
[TBL] [Abstract][Full Text] [Related]
10. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
12. Screening for oral precancer with noninvasive genetic cytology.
Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and DNA ploidy in oral leukoplakia.
Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
[TBL] [Abstract][Full Text] [Related]
14. Microspectrophotometric determination of DNA in oral lesions.
Giménez IB; Conti CJ
J Oral Surg; 1977 Jun; 35(6):465-8. PubMed ID: 266061
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
16. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
17. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma.
Abou-Elhamd KE; Habib TN
Oral Oncol; 2007 Apr; 43(4):366-72. PubMed ID: 16931118
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
19. Lack of molecular markers to predict malignant potential of oral precancer.
Warnakulasuriya S
J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
Thomas G; Tr S; George S P; Somanathan T; Sarojam S; Krishnankutti N; Sreedharan H; Ankathil R
Asian Pac J Cancer Prev; 2020 Feb; 21(2):309-316. PubMed ID: 32102504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
